Mesenchymal Stromal Cells in Knee Osteoarthritis: A Review of Nomenclature, Criteria, and Therapeutic Mechanisms
Therapeutics and Clinical Risk Management · 2026-05 · Volume 22 · 1-7
DOI: 10.2147/tcrm.s594869 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutics and Clinical Risk Management, 2026-05. Verfasst von Doo-Ho Lim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
- Department of Orthopedic Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
ORCID-Profile: Ki-Bong Park
Zitieren
APA
Lim, D. H., Lee, C. C., & Park, K. B. (2026). Mesenchymal Stromal Cells in Knee Osteoarthritis: A Review of Nomenclature, Criteria, and Therapeutic Mechanisms. Therapeutics and Clinical Risk Management, Volume 22, 1-7. https://doi.org/10.2147/tcrm.s594869
Vancouver
Lim DH, Lee CC, Park KB. Mesenchymal Stromal Cells in Knee Osteoarthritis: A Review of Nomenclature, Criteria, and Therapeutic Mechanisms. Therapeutics and Clinical Risk Management. 2026;Volume 22:1-7. doi:10.2147/tcrm.s594869
BibTeX
@article{Lim2026,
author = {Lim, Doo-Ho and Lee, Chae-Chil and Park, Ki-Bong},
title = {Mesenchymal Stromal Cells in Knee Osteoarthritis: A Review of Nomenclature, Criteria, and Therapeutic Mechanisms},
journal = {Therapeutics and Clinical Risk Management},
year = {2026},
volume = {Volume 22},
pages = {1--7},
doi = {10.2147/tcrm.s594869}
}
EUVIMED